Parsons Corp. won a $24 million contract to support the Naval Medical Research Command’s efforts to counter biological and chemical warfare. The deal includes a 1-year base period and four one-year options.
Parsons will continue supporting NMRC’s Biological Defense Research Directorate by advancing research to quickly detect infectious diseases relevant to the Defense Department and strengthen global disease surveillance for early threat detection and response.
“At Parsons, our team of world-class scientists combined with our industry-leading biodefense capabilities play a pivotal role in advancing the federal government’s efforts to counter biological threats,” said Jon Moretta, Parsons president of engineered systems,.“We look forward to continuing this critical work with the Naval Medical Research Command in defending U.S. military personnel stationed around the world from threats to their health and safety.”
Parsons has performed this work since 2018, providing the NMRC with scientists who are subject matter experts in molecular biology, immunology, serology, bacteriology, laboratory science and management, field collection and detection, outbreak response, reagent production and assay development.